An official UK government report --quoted extensively in Britain's tabloid media-- is warning the British public that there will be countless deaths in the case of a swine flu pandemic. According to the WHO, a Worlwide public health emergency situation will take place in the Fall.

A high death toll is predicted without corroborating evidence.

The official report confirms government plans to set up mass graves for the victims of the swine flu pandemic:

"Plans for mass graves have been drawn up to cope with a second wave of swine flu this Autumn. The chilling proposals are spelled out in a Home Office document discussed at a meeting of Whitehall officials and council leaders last month.

It warns emergency plans may be needed in areas where there are not enough graves to cope.

The 59-page document talks about using "a grave that is for a number of unrelated persons, excavated mechanically in advance and designed for efficient preparation and use". (The Sun, Augsut 19, 2009)

The mass graves, according to the report, "are being planned to deal with the rising death toll from swine flu if the pandemic escalates":

"The grim revelation will see the mass burial sites dug in advance to cope with any potential crisis.

The Government is planning to create a series of communal graves to cope with the second outbreak expected in the autumn and through the winter.

A Home Office document published earlier this year sets out plans for how local councils should deal with a high death toll – estimates of the number of deaths range from 55,000 to as high as 750,000 from the H1N1 killer virus – including setting up temporary mortuaries.

So far, 44 people in England have been confirmed as dying after contracting swine flu and another five have died in Scotland. The document says that while most cemeteries have sufficient burial capacity for a number of years, this could be put to the test at the peak of a pandemic. (Daily Express, August 19, 2009)

The chilling proposals contained in the government report serve to intimidate the British public and create an atmosphere of panic. A public health crisis is being planned in a diabolical fashion. .

The report suggests unequivocally that there will be countless deaths resulting from the level 6 WHO pandemic, which require the development of mass graves:

Within weeks of a full-blown pandemic emerging, the number of burials could more than double. Inner city areas “may experience a shortage of grave space”, the report stated.

Freight containers and “inflatable” storage units may be needed to provide extra mortuary space. But it stated that “refrigerated vehicles and trailers should not be used”.

Other contingency plans being suggested were the need for cemeteries and crematoriums to work seven days a week and to hire extra staff to cope with demand.

There may also be a need for more “basic and shorter services at the chapel” or for “memorial services” to be held at a person’s home instead.

Retired doctors could be called back to work to issue death certificates so GPs can focus on patients, while NHS Blood and Transplant has appealed to the public to give blood to ensure banks were well stocked.

A Home Office spokeswoman said: “This is prudent, precautionary planning that has been taking place over a number of years, with the health service, other essential services and local authorities. It is important to stress that these are possible scenarios, not certainties, so that our stakeholders can plan for the worst and be prepared to deal with the outbreak effectively.” (Ibid)

These assertions are totally fabricated. There is absolutely no scientific evidence to support these claims.

Realities are turned upside down. The British government is deliberately misleading the British public.

With some exceptions, the British media bears a heavy burden of responsibility in failing to analyse these "authoritative" statements emanating from Her Majesty's Government.

The WHO has not provided the evidence, nor has the British government.

There is ample evidence, documented in numerous reports, that the WHO's level 6 pandemic alert is based on fabricated evidence and a manipulation of the figures on mortality and morbidity resulting from the N1H1 swine flu.

The data initially used to justify the WHO's Worldwide level 5 alert in April 2009 was extremely scanty.

The WHO asserted without evidence that a "global outbreak of the disease is imminent". It distorted Mexico's mortality data pertaining to the swine flu pandemic. According to the WHO Director General Dr. Margaret Chan in her official April 29 statement: "So far, 176 people have been killed in Mexico". From what? Where does she get these numbers? 159 died from influenza out of which only seven deaths, corroborated by lab analysis, resulted from the H1N1 swine flu strain, according to the Mexican Ministry of Health.

The swine flu has the same symptoms as seasonal influenza: fever, cough and sore throat. What is happening is that the widespread incidence of the common flu is being used to generate the data pertaining to the H1N1 swine flu.

And all of sudden, the British authorities are predicting widespread mortality resulting from an influenza related ailment. What is the evidence. Big Pharma is behind the official reports and the media disinformation campaign.

Similarly, in the US the intervention of the military (as well as martial law provisions) are being envisaged in the case of a public health emergency.

Is this emergency being planned ahead of time. Are these various national emergencies (Britain, France UK) being coordinated through inter-governmental consultations, which serves to trigger a Worldwide public health emergency, based on fabricated evidence?

Deadly Vaccines

On the other hand, amply documented and denied by Western governments, the proposed vaccines could result in more deaths than those caused by the H1N1 influenza, as confirmed by Britain's Health Protection Agency:

A warning that the new swine flu jab is linked to a deadly nerve disease has been sent by the Government to senior neurologists in a confidential letter.

The letter from the Health Protection Agency, the official body that oversees public health, has been leaked to The Mail on Sunday, leading to demands to know why the information has not been given to the public before the vaccination of millions of people, including children, begins.

It tells the neurologists that they must be alert for an increase in a brain disorder called Guillain-Barre Syndrome (GBS), which could be triggered by the vaccine.

GBS attacks the lining of the nerves, causing paralysis and inability to breathe, and can be fatal.

The letter, sent to about 600 neurologists on July 29, is the first sign that there is concern at the highest levels that the vaccine itself could cause serious complications.

It refers to the use of a similar swine flu vaccine in the United States in 1976 when:

* More people died from the vaccination than from swine flu.

* 500 cases of GBS were detected.

* The vaccine may have increased the risk of contracting GBS by eight times.

* The vaccine was withdrawn after just ten weeks when the link with GBS became clear.

* The US Government was forced to pay out millions of dollars to those affected. (Mail on Sunday, August 16, 2009)

The British government has announced that more than 13 million people will be innoculated. The proposed vaccines for the H1N1 swine flu have not, as yet, been tested.

by Walter Burien08/20/09 Pay special attention to the strains of the H1N1 noted in the 2007 filing. Coming to your hometown soon!

The following is my reply to John Perna per a US Patent Application filed, with one aspect of the patent being for the Swine Flue virus vaccine (H1N1). The patent application was filed long before the Mexican Swine Flu supposedly came forward as a new strain of virus coming out of a "Pig Farm" in Mexico.

In John's post copied in part below my reply, he thought the patent application for the H1N1 vaccine was from 2008 shortly before the swine flue broke out in Mexico.

I am familiar with patents, so I took a look at the US Patent and Trademark site to verify what he was bringing forward was correct and found he was in error. The original application was actually filed in 2007. Long before the virus was staged as an outbreak of "a new viral strain" in Mexico.

As far as I am concerned, this now verified information puts the last nail in the coffin for the immediate suspension of all forms of "civil" government in this country for reorganization under limited purview and then reinstatement. And I hope, no I pray that when done in end result they axe 85% or more of the attorneys from the system. That is 90% of the solution right there.Sent FYI from,

Walter Burien - CAFR1.com

PS: Make the investment wealth of government directly benefit the people and taxation be gone! TRF now!------------------------Any local government can be restructured to meet their annual budget needs "Without" taxes. TRF (Tax Retirement Funds) paying for every City, County, State’s annual budgetary needs!------------------------

COMMUNICATION TO JOHN PERNA:

------------------------------------------------------

John:

Please send this to all of your contacts and media groups.

You are off on the filing date. It is not 08/28/2008 it is 08/28/2007 one year earlier! A Much Bigger smoking gun then you thought...

The 2008 date was when the Patent Application was put into final acceptance for examination. The filing date (when received in the PTO mail room) was exactly one year earlier. I put the links below from the US Patent and Trademark Office to verify this. You can also download any of the sections or copy from those pages and I strongly recommend that you do so. (the patent could be by amendment classified as secrete and pulled)

Here is the US Patent office link to see that patent - http://aPrison Planet Forumt.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=3&f=G&l=50&co1=AND&d=PG01&s1=Kistner.IN.&OS=IN/Kistner&RS=IN/Kistner

And yes the the Swine Flu virus H1N1 is listed "with many others" as copied from the Patent Application here at: [0056] "A vaccine can be used e.g. for an injection as a prophylactic means against a virus associated disease. In particular preferred embodiments the composition or vaccine comprises more than one antigen, e.g. 2, 3, 4, 5, 6, 7 or 8, in particular of different virus strains, subtypes or types such as influenza A and influenza B, in particular selected from of one or more of the human H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, H10N7 subtypes, of the pig flu H1N1, H1N2, H3N1 and H3N2 subtypes, of the dog or horse flu H7N7, H3N8 subtypes or of the avian H5N1, H7N2, H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2, H8N4, H14N5, H6N5, H12N5 subtypes. "

My additional concern is all the others virus vaccines listed but not yet promoted yet, get my point? !!

You may want to get this into a few specialists hands for comment immediately.

The following link is the most important. It shows that the original application was filed in 08/28/2007.

When it opens the page click on the tab "Image File Wrapper" then select "Specifications" and go to page "13" of the specifications. Here you will see the virus references to the viruses as noted above and it did so on "08/28/07" long before the virus was promoted as a "New and Deadly Strain" morphed out of a pig farm in Mexico.

So, upon my personal reflection of the matter: They can take that vaccine and shove it up their A** and what can't fit they can do the same to the US Propaganda ministry and their talking head wh***s in the syndicated news media that have promoted the swine flu frenzy.

Walter Burien - CAFR1.com

------------------------------------------ IN REPLY TO THE FOLLOWING:------------------------------------------

What is the difference between a needle shot in your arm and a bullet shot through your brain?

ANSWER:

With a bullet shot through your brain, your death will be quick and painless.

With a needle shot in your arm, your death will be slow, painful, and very profitable for drug and health care companies of which the predominate collective stock holders in those companies who will profit the most is your own government as your tax revenue is funneled into them to the tune of hundreds of billions of dollars. More people have died from the vaccination than from swine flu.

The vaccines are far more deadly than the swine flu. Mass vaccinations is a recipe for disaster Dr. Mae-Wan Ho and Prof. Joe Cummins

This report has been submitted to Sir Liam Donaldson, Chief Medical Officer of the UK, and to the US Food and Drugs Administration

A swine flu outbreak occurred in Mexico and the United States in April 2009 and spread rapidly around the world by human-to human transmission. The new type A H1N1 influenza virus is unlike any that had been previously isolated [1, 2], judging from the first data released in May.

It is a messy combination of sequences from bird, human and swine flu virus lineages from North America and Eurasia. A senior virologist based in Canberra, Australia, told the press he thought that the virus could have been created in a laboratory and released by accident [3]. Some analysts even suggest, without corroborating evidence, that it was made intentionally as a bioweapon [4], while others blame the intensive livestock industry and extensive trafficking of love animals over long distances, which provide plenty of opportunity for generating exotic recombinants [5].

But what worries the public most is the mass vaccination programmes governments are putting in place to combat the emerging pandemic, which could well be worse than the pandemic itself.

Watchdog opposes fast-track vaccine for school children

The US government is intending to vaccinate all children in September when school re-opens, and the country’s vaccine watchdog National Vaccine Information Center (NVIC) has called on the Obama Administration and all state Governors to provide evidence that the move is [6] “necessary and safe”, demanding “strong mechanisms for vaccine safety screening, recording, monitoring, reporting and vaccine injury compensation.”

The US Departments of Health and Homeland Security had declared a national public health emergency in April soon after the swine flu outbreak. As a result, some schools were closed, people quarantined, and drug companies were given contracts worth $7billon to make vaccines that are being fast tracked by the Food and Drugs Administration [7]. That means they will only be tested for a few weeks on several hundred children and adult volunteers before being given to all school children this fall.

Furthermore, under federal legislation passed by Congress since 2001, an Emergency Use Authorization allows drug companies, health officials and anyone administering experimental vaccines to Americans during a declared public health emergency to be protected from liability if people get injured. US Secretary of Health and Human Services Kathleen Sebelius has granted vaccine makers total legal immunity from any lawsuits that may result from any new swine flu vaccine. And some states may make the vaccination mandatory by law.

The NVIC is asking whether the states are prepared to obey vaccine safety provisions in the 1986 National Childhood Vaccine Injury Act, which include: 1. Giving parents written information about vaccine benefits and risks before children are vaccinated; 2. Keeping a record of which vaccines the children get, including the manufacturer’s name and lot number; 3. Recording which vaccines were given in the child’s medical record; and 4. Recording serious health problems that develop after vaccination in the child’s medical record and immediately making a report to the federal Vaccine Adverse Event Reporting System.

NVIC also wants to know if the states are prepared to provide financial compensation to children injured by the swine flu vaccines, whether parents will be given “complete, truthful information about swine flu vaccine risks”, and have the right to say “no” to vaccination.

Co-founder and president of NVIC Barbara Loe Fisher said [6]: “Parents and legislators should be asking themselves right now: Why are children the first to get experimental swine flu vaccines? Are schools equipped to get signed informed consent from parents before vaccination, keep accurate vaccination records and screen out children biologically at high risk for suffering vaccine reactions? Will people giving these vaccines know how to monitor children afterwards and immediately record, report and treat serious health problems that develop? And will states have the financial resources to compensate children who are injured?”

WHO and mass vaccination fever

The mass vaccination order has come from the World Health Organization (WHO) [8]. In early July 2009, a group of vaccination experts concluded that the pandemic is unstoppable, and Marie-Paul Kieny, WHO director on vaccine research said all nations will need access to vaccines, and that a vaccine should be available as early as September.

Critics point out that the ‘vaccination experts’ are dominated by the vaccine makers standing to gain from the enormously lucrative vaccine and antiviral contracts awarded by governments. But the decisive argument against mass vaccinations is that flu shots simply don’t work and are dangerous [9].

Flu shots ineffective and increase risks of asthma

There are widely acknowledged reasons why flu vaccines won’t work, as already pointed out with regard to the much touted vaccines against the ‘pandemic bird flu’ that has yet to materialize [10] (How to Stop Bird Flu Instead, SiS 35). The flu virus changes quickly - even without the help of genetic engineering in the laboratory, and especially with the help of the intensive livestock industry - whereas the vaccines target specific strains. Furthermore, flu vaccination does not give permanent protection, and must be repeated annually; the vaccines are difficult to mass-produce, and some strains won’t grow at all under laboratory conditions.

Numerous studies have documented that flu shots give little or no protection against infection and illness, and there is no reason to believe that swine flu vaccines will be different.

A review of 51 separate studies involving more than 294 000 children found that in children aged from two years, nasal spray vaccines made from weakened influenza viruses and injected vaccines made from the killed virus prevented 82 and 59 percent of illnesses. The prevention of 'flu-like illness' caused by other types of viruses was only 33 and 36 percent respectively. In children under the age of two, the efficacy of inactivated vaccine was similar to placebo. It was not possible to analyse the safety of vaccines from the studies due to the lack of information, and lack of standardization on the little information available [11]. A report published in 2008 found flu vaccines in young children made no difference in the number of flu-related doctor and hospital visits [12].

On the other hand, a study of 800 children with asthma found that those receiving a flu vaccine had a significantly increased risk of asthma-related doctor and emergency room visits [13]; the odds ratios were 3.4 and 1.9 respectively. This was confirmed in a report published in 2009, which showed children with asthma who received FluMist had a 3-fold increased risk of hospitalization [14]

Flu vaccines are equally useless for adults, including the elderly, giving little or no protection against infection or illnesses including pneumonia (see [9]).

Toxic adjuvants in flu vaccines

Vaccines themselves can be dangerous, especially live, attenuated viral vaccines or the new recombinant nucleic acid vaccines [10], they have the potential to generate virulent viruses by recombination and the recombinant nucleic acids could cause autoimmune diseases.

A further major source of toxicity in the case of the flu vaccines are the adjuvants, substances added in order to boost the immunogenicity of the vaccines. There is a large literature on the toxicities of adjuvants. Most flu vaccines contain dangerous levels of mercury in the form of thimerosal, a deadly preservative 50 times more toxic than mercury itself [9]. At high enough doses, it can cause long-term immune, sensory, neurological, motor, and behavioural dysfunctions. Also associated with mercury poisoning are autism, attention deficit disorder, multiple sclerosis, and speech and language deficiencies. The Institute of Medicine has warned that infants, children, and pregnant women should not be injected with thimerosal, yet the majority of flu shots contain 25 micrograms of it.

Another common adjuvant is alum or aluminium hydroxide, which can cause vaccine allergy, anaphylaxis, and macrophage myofascitis, a chronic inflammation syndrome, In cats, alum also gives rise to fibrosarcomas at the site of injection [15]. Numerous new adjuvants are no better, and could be worse. According to a recent review in a science and business pharmaceutical publication [15], most newer adjuvants including MF59, ISCOMS, QS21, AS02, and AS04 have “substantially higher local reactogenicity and systemic toxicity than alum.”

Current status of swine flu vaccines

Five different companies have been contracted to produce vaccines worldwide: Baxter International, GlaxoSmithKline, Novartis and Sanofi-Aventis and AstroZeneca [16]. Already stretched beyond capacity, there is every intention to make smaller vaccine doses go further with a range of new adjuvants [17], with the blessing of the WHO (see later).

Flu vaccines are traditionally produced from non-virulent (attenuated or weakened) influenza viruses (see Box for a description of the viruses). To be effective, the genes of the non- virulent virus used must match those of the viral strain spreading in the population. Activation of the immune system by exposure to the non pathogenic form of the circulating pathogenic strain leads to the production of antibodies that will confer protection against the pathogenic strain. Producing the non-virulent virus involves first identifying and then recreating the subtypes of two of the virus’s surface proteins, haemagglutinin (H) and neuraminidase (N), which determine the strain’s virulence and ability to spread, and are also the target proteins for vaccine production.

Influenza viruses

There are 3 types of influenza viruses, A, B and C. The influenza A type virus is the main one that cause diseases in birds and mammals. Its genome consists of 8 segments of RNA coding for 11 proteins, and the viruses are further classified by subtype on the basis of the two main surface glycoproteins (proteins with complex carbohydrate side chains): haemagglutinin (H) and neuraminidase (N) [18]. The segmented genome enables the virus to’ reassort’ (shuffle) segments as well as recombine within segments, thereby greatly increasing the rate of evolution and generation of new strains. Reassortment is also widely exploited in the laboratory in the process of creating vaccine strains. To-date, 16 H and 9 N subtypes have been detected in numerous combinations circulating in wild birds [19].

Seed viruses are first made to provide the starting material for large scale production of live non-virulent flu viruses. The seed viruses are approved by the WHO or the United States Food and Drug Administration (USFDA). The usual method of seed virus production is reassortment (see Box). Fertilized chicken eggs are injected with both a standard non-pathogenic influenza strain known to grow well in eggs and the strain that carries the genes expressing the desired vaccine H and N protein subtypes. The two viruses multiply, and their eight genome segments reassort with 256 possible combinations. The resulting recombinant viruses are then screened for the desired virus with the six genome segments that allow the standard strain to grow so well in eggs and the H and N genes from the circulating strain. The seed virus is then injected into millions of eggs for mass production of vaccine. This conventional method of seed stock production takes about one to two months to complete [20].

Cell culture systems may eventually replace chicken eggs. Baxter International applied for a patent on a process using cell culture to produce quantities of infecting virus, which are harvested, inactivated with formaldehyde and ultraviolet light, and then detergent [21]. Baxter has produced H5N1 whole virus vaccines in a Vero cell line derived from the kidney of an African green monkey, and conducted phase 1 and 2 clinical trials with and without aluminium hydroxide as adjuvant [22, 23]. The main finding was that the toxic adjuvant did not increase neutralising antibodies against the vaccine strain. Baxter has agreed to ship H1N1 vaccine by the end of July or early August 2009 but details of the production of that vaccine have not yet been released to the public [16].

In December, a Baxter facility in Austria sent a human flu vaccine contaminated with the deadly H5N1 live avian flu virus to 18 countries, including the Czech Republic, where testing showed it killed the ferrets inoculated [24]. Czech newspapers questioned whether Baxter was involved in a deliberate attempt to start a pandemic.

Norvatis, another big pharma, announced on 13 June that it, too, has produced a swine flu vaccine using cell-based technology and the proprietary adjuvant MF59®. The MF59® adjuvant is oil based and contains Tween80, Span85, and squalene [25]. In studies of oil-based adjuvants in rats, the animals were rendered crippled and paralyzed. Squalene brought on severe arthritis symptoms in rats, and studies in humans given from 10 to 20 ppb (parts per billion) of squalene showed severe immune system impact and development of autoimmune disorders [26].

Novartis was in the news in 2008 for a clinical trial of a H5N1 vaccine in Poland. The trial was administered by local nurses and doctors who gave the vaccine to 350 homeless people, leaving 21 died; and were prosecuted by the Polish police [27, 28]. Novartis claimed the deaths were unrelated to the H5N1 vaccine [29], which had been “tested on 3500 other people without any deaths.”

GlaxoSmithKline’s vaccine will be made up of antigens of the recently isolated influenza strain, and also contains its own proprietary adjuvant system AS03 that has been approved in the EU along with its H5N1 bird flu vaccine in 2008. According to the European Public Assessment Report [30], AS03 adjuvant is composed of squalene (10.68 milligrams), DL-α-tocopherol (11.86 milligrams) and polysorbate 80 (4.85 milligrams). The H5N1 vaccine also contains 5 micrograms thiomersal, as well as Polysorbate 80, Octoxynol 10, and various inorganic salts. The company is aggressively promoting various adjuvant systems as its ‘adjuvant advantage’ that reduces the dose of vaccines [31].

A recent WHO survey of primary vaccine producers concluded that the potential output of 4.9 Billion doses of H1N1 vaccine per year is a best-case scenario, assuming among other factors that the most dose-sparing formulation (that will include toxic adjuvants) be selected by each manufacturer and that production will take place at full capacity. WHO Director-General, Dr .Margaret Chan, and the United Nations Secretary-General, Mr Ban Ki-moon, met with senior officials of vaccine manufacturers on 19 May and asked them to reserve part of their production capacity for poor countries that would otherwise have no or little access to vaccine in the case of a pandemic [32].

The last mass-vaccination in the US was a disaster. In 1976, cases of swine flu were found in soldiers at Fort Dix, New Jersey, and one of them died, most likely of physical overexertion rather than from the infection [7]. This led to the launch of a mass vaccination of 40 million against a pandemic that never materialized. Thousands filed claims for injury. At least 25 died and 500 developed paralyzing Guillain-Barre syndrome [33, 34].

Swine flu syndromes mostly mild

As of 22 July 2009, the CDC listed a total of 40 617 cases in the US, with 319 fatalities, giving a fatalites/case ratio of 0.8 percent [35]; though the real death rate – among all cases of infection including the mild ones that go unreported – is probably much lower. Experts estimate that only 1 out of 20 cases are reported [36].

The UK is the worst affected European country, and the pandemic is in the headlines everyday in July. A new telephone helpline was set up on 23 July to let people get advice and tamiflu without seeing a doctor. In that week, there has been a record rise in cases to 100 000 and a total of 30 deaths so far [37], giving a fatalities/case ratio of 0.03 percent, a more accurate reflection of the actual death rate.

UK’s chief medical officer Sir Liam Donaldson has ordered the NHS to plan for as many as 65 000 deaths, with 350 a day at the peak [38]. There has been no plan as yet for mass vaccination; but the UK government has advance orders for 195 million doses of vaccine with GlaxoSmithKline (GSK).

The vaccine that GSK is developing will be tested on a limited number of people as the UK drug company reportedly [39] “weighs the pandemic danger against the risks of an unsafe shot.” This was criticized as “risky” by Prof. Hugh Pennington, a retired microbiologist at the University of Aberdeen, Scotland. “By limiting clinical trials, Glaxo raises the danger that the vaccine dose isn’t properly calibrated, and could lead to shots that don’t protect people from the virus or at worse are unsafe,” Pennington said.

Pennington added that the shot’s ability to trigger the body’s defences is crucial and requires tests to determine the best dose and whether an adjuvant is needed to bolster the immunity. (As we know, GSK is definitely promoting its new range of toxic adjuvants.) He also referred to the Fort Dix incident in 1976 (see earlier).

France has ordered vaccines from Sanofi, GSK and Novartis, but sees no reason to ask vaccine makers to shorten or skip clinical trials [16]. Sanofi-Aventis, the French drug maker developing its own swine flu vaccine will begin testing the product in early August, and estimates it will need as much as two and a half months of tests before having a shot that’s “both safe and protective”, according to Albert Garcia, speaking for the company’s vaccine unit, “the vaccine will be ready in November or December, he said.

Baxter, however, will produce a vaccine by early August for clinical tests.

Glaxo also said it is developing a face mask coated with antivirals to prevent infection and boosting production of its Relenza drug for patients already suffering from swine flu.

There are obviously safer and more effective ways to combat the pandemic than mass vaccinations: washing hands often, sneezing into a tissue that can be safely disposed of, avoiding unnecessary gatherings, and delay opening schools – all advised by governments - and we would add, eating healthily, exercise, and getting enough vitamin D to boost your natural immunity [10].

I just sent off a bunch of information to her to see what the response will be, it would be great if some of you on Prison Planet Forum could do the same & back it up with the truth & facts with proof about the Swine flu vaccine just like you do here.

I added that she will be held accountable for the deaths of many Australians

MARK COLVIN: The country's top infectious diseases body has written to the Government to warn that the swine flu vaccine is being distributed too hastily, with too many risks for the public.

The Australasian Society for Infectious Diseases says the vaccine will come in multi-dose vials.

It says these have been shown to transmit infection, spread HIV and hepatitis and even cause death.

The Federal Health Minister Nicola Roxon says the Government expects to receive two million doses by the end of next week, and a widespread immunisation program could start by mid-September.

But the infectious diseases doctors say the swine flu threat has now passed, and there's no need for urgent mass vaccination.

Dina Rosendorff reports

DINA ROSENDORFF: It's unusual to hear a doctor speak out like this:

TOM GOTTLIEB: To rush to a massive vaccination using multi-dose vials that have been associated with problems in the past, seems too hasty and perhaps not measured enough for our society.

DINA ROSENDORFF: Dr Tom Gottlieb is the President of the Australasian Society for Infectious Diseases, which represents about 400 clinicians nationally.

The doctors are worried about the method that will be used to deliver the swine flu vaccine, when the national immunisation program starts in the next few weeks.

The plan is to use multi-dose vials of the vaccine. That means a health worker will use needles to take more than one dose out of each vial.

TOM GOTTLIEB: There have been episodes of bacterial contamination of vaccines, where there has been perhaps a bacterial organism growing in the vaccine, and when the patient's been injected they may have become infected with a bacteria.

Now that's largely been addressed with preservatives that are used in vaccines, but nonetheless, there are potentials for viruses from one patient to be transmitted if vaccination is not done correctly. And in most circumstances it would be done correctly, but when things are rolled out hastily and multi-dose vials are used that potential exists and there are certainly examples of spread of infection between patients with HIV, hepatitis B, hepatitis C and so on and that's our concern.

DINA ROSENDORFF: The group of infectious diseases doctors is so concerned that they've written to Australia's Chief Medical Officer, Jim Bishop, urging him to reconsider the vaccination strategy.

In the letter, the doctors point out that many international agencies including The World Health Organisation prefer the use of single-dose vials.

But the drug company making the vaccine says it would take too long to make enough single-dose vials.

Dr Rachel David is a spokeswoman for CSL.

RACHEL DAVID: It would delay the role out of the vaccine by a long time. The other reason is that with pre-filled syringes you need to order a lot of syringes to roll out the vaccine for 21 million doses as the Government has ordered. So I think on balance the decision to use multi-dose vials is completely justified.

DINA ROSENDORFF: Is it a cost saving measure?

RACHEL DAVID: Look, although it will work out being cheaper to use multi-dose vials, it's not being done this way to save money. It's been done this way to vaccinate a large number of people quickly, which is our best chance of stopping the flu epidemic.

DINA ROSENDORFF: But Dr Gottlieb says there's no real need to rush.

He says there have been fewer deaths linked to swine flu than initially feared, and the epidemic has now subsided.

TOM GOTTLIEB: Our society, all the members are strong advocates of vaccinations, so in no ways do we want to undermine vaccination as a very effective strategy. But in this particular influenza season, we have to determine which are the risk groups that need vaccination, and the probable urgency is no longer there as it was perhaps a few months ago. And we would caution for a more measured approach and for single dose vaccines to be used preferably to multi-dose vials.

DINA ROSENDORFF: But that argument has done nothing to change the mind of Australia's Chief Medical Officer.

Professor Jim Bishop is yet to sign off on the swine flu vaccine rollout, but he's indicated that when he does, multi-dose vials will be used.

In a statement, he's told PM that health workers will be trained to maximise infection control and minimise wastage.

The Federal Health Minister, Nicola Roxon, says the Government is likely to take delivery of two million doses by the end of next week.

NICOLA ROXON: It's anticipated that by the middle or end of September we would be starting to vaccinate the priority groups and those priority groups are of course the most vulnerable that we would hope to be able to reach as quickly as possible. And we are certainly doing everything we can to make sure that the vaccine is available and that implementation plans are ready to go as soon as we do get that tick off.

DINA ROSENDORFF: The first jabs will go to pregnant women, health workers and people with underlying medical conditions.

MARK COLVIN: Dina Rosendorff.

Logged

12160 "Destroying the NWO"Check out the blogs, videos, and discussions!!http://12160.info/

At least two Dolphins players have reportedly tested positive for swine flu and will not attend Saturday night's game against the Panthers.Names have been withheld while the team's medical staff works to quarantine the infected players and make sure that other players maintain proper hygiene to prevent an outbreak. The World Health Organization expects cases to double every three-to-four days until cold weather returns in the Northern Hemisphere. Aug. 22 - 2:00 pm et

At least two Dolphins players have reportedly tested positive for swine flu and will not attend Saturday night's game against the Panthers.Names have been withheld while the team's medical staff works to quarantine the infected players and make sure that other players maintain proper hygiene to prevent an outbreak. The World Health Organization expects cases to double every three-to-four days until cold weather returns in the Northern Hemisphere. Aug. 22 - 2:00 pm et

it's just as well, the hero worship of sports and the stars of those sports is out of balance and a huge opiate for the masses.

Logged

"I do not believe that there were, at the Council of Nicea, three persons present who believed in the truth of what was set down.If there were, it was on account of their ignorance."J. M. Roberts, "Antiquity Unveiled", 1892

More than half of children taking the swine flu drug Tamiflu experience side effects such as nausea and nightmares.

Studies of 103 children showed that 51 to 53 percent had one or more side effects from the medication.

The most common side effect was nausea (29 percent), followed by stomach pain or cramps (20 percent) and problems sleeping (12 percent). Almost one in five had a “neuropsychiatric side effect,” such as inability to think clearly, nightmares and “behaving strangely.”

The UK has set up a hotline and Web site that allows people with flu symptoms to be prescribed Tamiflu without having to see a doctor. It’s estimated that about 150,000 people have received the drug through the hotline/Web site so far.

Now the British Medical Association’s lead expert on swine flu, Peter Holden, has said Tamiflu is being overused and does not need to be given to everyone with mild symptoms. In fact, he pointed out that in people who are not in high-risk groups, the swine flu virus “typically causes mild symptoms and does not require a course of Tamiflu.”

Before you take a medication, or give one to your child, it’s always wise to examine the benefits versus the risks. In the case of swine flu, most often the symptoms are mild and resolve on their own. Taking Tamiflu, on the other hand, caused side effects ranging from nausea to neuropsychiatric side effects, such as inability to think clearly, in over half the children who took the drug.

Tamiflu is NOT a Safe Drug … And it’s Not Very Effective Either

You may be able to justify taking a flu drug like Tamiflu if you’re only risking a bit of stomach upset and it truly worked to get rid of the flu -- but that’s often not the case with Tamiflu.

The drug is part of a group of anti-influenza drugs called neuraminidase inhibitors, which work by blocking a viral enzyme that helps the influenza virus to invade cells in your respiratory tract.

Serious side effects include convulsions, delirium or delusions, and 14 deaths in children and teens have been reported as a result of neuropsychiatric problems and brain infections. Japan actually banned Tamiflu for children in 2007 because of the steep risks.

It was also around this time that the U.S. FDA began reviewing reports of abnormal behavior and other brain effects in more than 1,800 children who had taken Tamiflu.

Further, the drug commonly causes a myriad of side effects that, ironically, resemble the flu symptoms the drug claims to treat, including:

Nausea Vomiting Diarrhea Headache Dizziness Fatigue Cough For risking all of these side effects, what do you get in return? Well, when Tamiflu is used as directed (twice daily for five days) it can only reduce the duration of your flu symptoms by 1 to 1.5 days, according to official data!

So to summarize this more clearly, if you take Tamiflu you’re taking a drug that has a chance of killing you, was banned in Japan, is loaded with side effects that mimic the flu itself, costs over $100 and at best can only provide 36 hours of symptom relief.

While this scenario is not likely to offer much of a benefit to you, it does offer major benefits to Tamiflu’s manufacturers. The Financial Times reports that governments around the world have previously stockpiled 220 million doses of the drug in preparation for a pandemic that has yet to appear -- at a cost of $7 billion.

What Can You do to Avoid the Flu … And Tamiflu?

I strongly believe taking Tamiflu to protect yourself against swine flu or any flu could be a serious mistake. In addition to the dangerous side effects I mentioned above, there is also growing evidence of resistance against the drug … which is just one more reason not to bother with it.

Fortunately, there are many steps you can take to boost your immune health and fight off flu viruses naturally. I’ve posted this list before, but it’s so important I’m adding it here again. Please familiarize yourself with these top flu prevention tips, and share them with your friends and family members as well.

These are the steps that will keep you strong and healthy …something a flu drug will rarely do:

Optimize your vitamin D levels. Optimizing your vitamin D levels is one of the absolute best strategies for avoiding infections of ALL kinds, and vitamin D deficiency is likely the TRUE culprit behind the seasonality of the flu -- not the flu virus itself. This is probably the single most important and least expensive action you can take. I would STRONGLY urge you to have your vitamin D level monitored to confirm your levels are therapeutic at 50-70 ng.ml and done by a reliable vitamin D lab like Lab Corp.

For those of you in the US we hope to launch a vitamin D testing service through Lab Corp that allows you to have your vitamin D levels checked at your local blood drawing facility, and relatively inexpensively, soon. It the meantime, you can also take part in the D*Action Project to have your levels tested as part of a five-year study for public health.

If you are coming down with flu-like symptoms and have not been on vitamin D you can take doses of 50,000 units a day for three days to treat the acute infection. Some researchers like Dr. Cannell, believe the dose could even be as high as 1,000 units per pound of body weight for three days.

However, most of Dr. Cannell's work was with seasonal and not pandemic flu. If your body has never been exposed to the antigens there is chance that the vitamin D might not work. The best bet is to maintain healthy levels of vitamin D around 60 ng/ml.

Avoid Sugar and Processed Foods. Sugar decreases the function of your immune system almost immediately, and as you likely know, a strong immune system is key to fighting off viruses and other illness. Get Enough Rest. Just like it becomes harder for you to get your daily tasks done if you're tired, if your body is overly fatigued it will be harder for it to fight the flu. rest. Use Effective Tools to Address Stress. We all face some stress every day, but if stress becomes overwhelming then your body will be less able to fight off the flu and other illness. If you feel that stress is taking a toll on your health, consider using a tool such as the Meridian Tapping Technique (MTT), which is remarkably effective in relieving stress associated with all kinds of events, from work to family to trauma.

Exercise. When you exercise, you increase your circulation and your blood flow throughout your body. The components of your immune system are also better circulated, which means your immune system has a better chance of finding an illness before it spreads. Take a high-quality source of animal-based omega-3 fats like Krill Oil. It is also vitally important to avoid damaged omega-6 oils that are in trans fats and processed foods as it will seriously damage your immune response. Wash Your Hands. Washing your hands will decrease your likelihood of spreading a virus to your nose, mouth or other people. Be sure you don't use antibacterial soap for this -- antibacterial soaps are completely unnecessary, and they cause far more harm than good. Also be careful not to over-wash your hands, which can damage your skin and allow an entryway for pathogens. Eat Garlic Regularly. Garlic works like a broad-spectrum antibiotic against bacteria, virus, and protozoa in the body. And unlike with antibiotics, no resistance can be built up so it is an absolutely safe product to use. However, if you are allergic or don't enjoy garlic it would be best to avoid as it will likely cause more harm than good. Avoid Hospitals and Vaccines. In the case of swine flu, I recommend you stay away from hospitals unless you're having an emergency, as hospitals are prime breeding grounds for infections of all kinds, and could be one of the likeliest places you could be exposed to this new bug. Vaccines, when available, will likely be ineffective and may lead to crippling paralysis like Guillain-Barré Syndrome just as it did in the ‘70s.

Indiscriminate use of antiviral medications to prevent and treat influenza could ease the way for drug-resistant strains of the novel H1N1 virus, or swine flu, to emerge, public health officials warn -- making the fight against a pandemic that much harder.

Already, a handful of cases of Tamiflu-resistant H1N1 have been reported this summer, and there is no shortage of examples of misuse of the antiviral medications, experts say.

People often fail to complete a full course of the drug, according to a recent British report -- a scenario also likely to be occurring in the U.S. and one that encourages resistance. Stockpiling is rife, and some U.S. summer camps have given Tamiflu prophylactically to healthy kids and staff, and have even told campers to bring the drug to camp. Experts anticipate more problems in the fall as children return to school and normal flu season draws nearer.

"Influenza viruses mutate frequently and any viral resistance could be acquired easily," said Dr. Anne Schuchat, director of the National Center on Immunization and Respiratory Disease at the Centers for Disease Control and Prevention in Atlanta. "It won't surprise us if we see resistance emerge as a bigger problem in the fall or in the years ahead."

Prescribed in pill form, Tamiflu (oseltamivir) works by preventing the flu virus from leaving infected cells and spreading to new ones. Because a vaccine against pandemic H1N1 influenza will not be widely available for several months, Tamiflu and to a lesser extent Relenza (zanamivir), an antiviral that acts similarly, are key medical tools for fighting the pandemic in the meantime.

On Friday, however, the World Health Organization advised doctors that even those who are sickened with swine flu do not need to be given Tamiflu or Relenza if they are only mildly or moderately sick and are not in a high-risk group (such as children under 5, pregnant women and those with an underlying health condition).

Both drugs can help prevent illness in people exposed to the virus and reduce illness severity in people already sickened with it. On Aug. 14, after U.S. national soccer team forward Landon Donovan was diagnosed with H1N1 flu, players, coaches and support staff of the U.S. and Galaxy teams were advised to take Tamiflu as a preventive measure.

Tamiflu was chosen a few years ago for stockpiling by the federal government to deal with future pandemics.

Health authorities in the United States and elsewhere are keeping a sharp eye on prescriptions of the drug as they prepare for a surge of H1N1 cases in the fall. The U.S. government has issued detailed guidelines on prescribing antivirals. But health professionals may not follow the recommendations or may give in to patients who pester them for prescriptions that are ill-advised, said Dr. Robert Schechter, acting chief of the immunization branch of the California Department of Public Health.

"These medicines can be very helpful to those who could get very sick," Schechter said. "But excessive use will accelerate the development of resistance and lead to the lack of a medication for everybody."

Anxiety over indiscriminate use is growing, and taking the medications cavalierly is not without consequence. British health authorities reported Aug. 2 that cases of side effects from Tamiflu had doubled in the prior week, coinciding with the July 24 launch of a program in England to provide antivirals to anyone with H1N1 influenza who requests it over the phone or online.

In the first three days of the program, 150,000 packets of Tamiflu were dispensed and 293 cases of side effects were reported. Tamiflu can cause vomiting, diarrhea and mild neuropsychiatric effects.

Some U.S. health authorities have also expressed concern over misuse of the medications. Last month, the CDC urged directors of summer camps to stop handing out Tamiflu to healthy campers.

Americans are known to hoard antivirals: A 2006 study showed that heightened anxiety over a possible avian flu pandemic caused Tamiflu prescriptions to soar 300% in 2004 and 2005.

Just as with antibiotics, of central importance to antivirals' success is taking them properly, including completing the recommended course.

However, a study published in late July found poor adherence among children in London who took Tamiflu for prevention of pandemic H1N1 in the spring.

Less than half of the grade-school-age children and only 76% of the 13- and 14-year-old students completed a full course of medication.

More than half of the children reported side effects, such as nausea, stomach cramps and trouble sleeping. Almost one in five reported a neuropsychiatric side effect, such as poor concentration, confusion or bad dreams, even though the U.S. Food and Drug Administration says neuropsychiatric side effects are rare.

Moreover, a study published this week found that Tamiflu and Relenza are unlikely to prevent complications, such as asthma flare-ups or ear infections, in children who have seasonal influenza. But they do increase the risk of vomiting.

The authors of the study, published in the British Medical Journal, said they don't know if their findings can be generalized to the pandemic flu strain.

Antiviral drugs can be underutilized as well as overused, Schechter said. Some Californians who have died from novel H1N1 influenza did not receive antivirals.

"I'm afraid the medications are not being used in some instances where they should," he said. "But there are also international reports of resistance developing. Both of those extremes are concerning."

A handful of resistant H1N1 cases have been reported worldwide among people who had taken Tamiflu preventively: three in Japan, and one each in Canada, Hong Kong and Denmark.

Those cases are not surprising nor of great concern to health authorities, said Dr. Tim Uyeki, a medical epidemiologist with the CDC. They are cropping up sporadically and don't seem to be spreading from person to person.

"The most important question for public health is not whether sporadic cases occur but whether there is ongoing transmission of oseltamivir-resistant strains," Uyeki said.

The most perplexing case of Tamiflu resistance arose in June when a San Francisco teen who had flown to Hong Kong was found by authorities there to be ill with pandemic H1N1 flu. The girl, who recovered, had never taken Tamiflu.

A state investigation of people who were in close contact with the girl, as well as tests of 251 H1N1 virus samples from sick patients in California, has not turned up evidence of a resistant strain circulating here, Schechter said.

But nothing, in theory, would stop such a strain from developing, then circulating. In recent years, several strains of regular, seasonal H1N1 influenza have developed resistance to antiviral medications.

And a study published in March on the spread of the H5N1 avian flu, which has been circulating worldwide in bird flocks in recent years and has killed 262 people, showed the virus rapidly developed resistance to a different class of antiviral drugs, adamantanes.

"With bird flu, we found some resistance started in China and spread throughout the world in a few years," said study author Daniel Janies, an evolutionary biologist at Ohio State University. "Overuse contributes to resistance. Basic natural selection predicts it. We can demonstrate why you should not use these drugs unless you have to."

Other antiviral drugs exist, but the pandemic H1N1 virus is resistant to the adamantane class. If it develops resistance to Tamiflu also, only Relenza would be left to treat the illness, barring the development of new antiviral medications.

Relenza, Schechter said, is indicated only for ages 5 and older. Used less commonly than Tamiflu, it is inhaled as a powder, and people who are seriously ill or have difficulties with breathing cannot take it.

"The more choices you have, the better for treatment," Schechter said. "To lose any one of those options would pose great challenges for treatment of those who are most vulnerable or likely to die."

Logged

All eyes are opened, or opening, to the rights of man. The general spread of the light of science has already laid open to every view the palpable truth, that the mass of mankind has not been born with saddles on their backs, nor a favored few booted and spurred, ready to ride them legitimately

Can someone let Alex know that the 25 deaths were from the 1976 vaccine so he doesn't look like a fool claiming they're from the current H1N1 vaccine?

We're all searching constantly for any signs of death or illness from the current vaccine, and will raise the alarm when and if it happens, but let's keep our facts straight--we can't afford for Alex to lose credibility over something like this.

A growing number of doctors, other health professionals and citizens are attempting to prevent the humanitarian disaster planned for this October when the new H1N1 vaccine is to be deployed in a grand scale, military, war on terror manoeuvre .

"Primum non nocere" ("First do no harm"), medical ethics standard attributed to Hippocrates that became obligatory for physicians prior to practicing medicine in the 4th century AD is still upheld by some doctors who oppose the worldwide October plan including what Global Research Director, Michel Chossudovsky warns is a military operation leading to global militarization control of individuals.

LEADING infectious disease experts have called on the Federal Government to abandon its mass swine-flu vaccination plan because of fears the vaccine is a contamination risk that could spread blood-borne diseases.

Federal Advisory Committee Issues Guidelines For H1N1 Vaccine Campaign"Robin Robinson of the U.S. Department of Health and Human Services told the meeting the government has contracted to buy around 200 million doses of vaccine and that 20 million have been delivered," Reuters reports. Anne Schuchat of the CDC "said it still was not clear when vaccination could begin," but added, "We want people to plan as though we will be able to go in mid-October" (Bigg, 7/29).

Swine Flu Campaign Waits on VaccineOnly Third of Supply Is Expected for First Round of Vast Effort

To prepare, more than 2,800 local health departments have begun recruiting pediatricians, obstetricians, nurses, pharmacists, paramedics and even dentists, along with a small army of volunteers from churches and other groups.

Another wild card will be whether the vaccine will be delivered with an "adjuvant" to boost its effectiveness or stretch limited supplies into more doses. Adjuvants have been used in Europe, but the Food and Drug Administration has not authorized their use in the United States.

"This is an overreaction," said Barbara Loe Fisher of the National Vaccine Information Center, which opposes many vaccine policies. "There is no national security threat here. Why are we operating like this? This is not polio. This is not smallpox."

Fears and misinformation about the vaccine are circulating, including inaccurate claims that it will be mandatory.

"I'm very concerned about the dangers of vaccines," said Janice Smith, 58, of Misawaka, Ind., who attended a public hearing Aug. 15, one of a series of meetings the CDC has sponsored to gauge public sentiment about the vaccine.

Authorities are adamant that vaccination will be voluntary, and they say there is no reason to think the vaccine will be any less safe than the usual flu vaccine. An adjuvant will be used only if necessary and proven safe, they say.

To address concerns of pregnant women and parents with young children, some vaccine is being produced without a mercury additive. And because the short-term studies can identify only common, immediate side effects, the CDC will step up monitoring for rarer, serious complications such as Guillain-Barré.

"We're putting into place systems that are as good as we can have to identify problems quickly if they do occur," CDC Director Thomas R. Frieden said.

On Friday, officials reported that no "red flags regarding safety" had emerged in the clinical trials. "We are continuing oversight on the quality and safety of the vaccine being produced, and the production process itself," said Jesse Goodman of the FDA. "That's going well so far, but our oversight is continuing."

In the meantime, local officials are drafting plans tailored to their communities. The shots in the arms and squirts up the nose will happen in schools, medical offices, hospitals, public health clinics, workplaces, drug stores and at mass vaccination events, possibly including drive-through clinics in parking lots where people would stick their arms out their car windows for a stab.

The CDC is formulating a $4.8 million multimedia campaign to encourage people to get vaccinated and help alleviate concerns and confusion, including radio and television public service announcements, print ads, and messages delivered via Twitter, RSS feeds and video podcasts on YouTube.

Volunteers in the first of five studies of the vaccine got their first shots in the last two weeks, and so far no one has reported symptoms worse than a sore and swollen arm, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.

``There are no red flags regarding safety,'' said Fauci, at a Friday news conference.

That encouraged health officials to go forward this week with experiments testing the vaccine in children ages 6 months to 17 years, Fauci added.

There have been no serious side effects from the first set of injections of the new swine flu vaccine, federal health officials said Friday in predicting that nearly 200 million doses could be produced by year's end.

Clinical trials in adults began on Aug. 7, and those in children on Wednesday.

"There are no red flags regarding safety," said Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, which is overseeing the trials.

Because the only side effects in adults were sore arms, which are typical of any flu shot, trials on children were able to begin, and those in pregnant women are expected to begin early next month, Fauci said in a telephone news conference with officials from the Food and Drug Administration and the Centers for Disease Control and Prevention.

The vaccine will be tested in about 4,500 people. That is far too few to pick up subtle side effects, but the virus strain in the vaccine is close enough to one strain in seasonal shots so that side effects are expected to be similar.

The trials will help officials decide whether to recommend one dose or two. Even with seasonal flu shots, young children who have never had the flu sometimes need two doses to get a "take" — vaccinologist jargon for a protective immune response.

Unless the virus changes, health officials do not expect to recommend mixing in adjuvants. Adjuvants, usually oil-water emulsions orAdvertisementaluminum salts, boost the immune system but also often heighten unpleasant side effects.

Since it was first detected in April, the pandemic virus has not produced any nasty new surprises during its spread around the world, said Dr. Jay C. Butler, director of the H1N1 Vaccine Task Force at the CDC.

AFP News Briefs List

Swine flu looms over global economic recovery

Markets around the globe have started to celebrate the first signs of economic recovery, but experts have warned that a possible resurgent swine flu could still take a toll of productivity and financial systems.

First reported four months ago, the new A(H1N1) influenza virus spread by June into a global pandemic with some 1,800 deaths and now affects more than 170 countries, according to the World Health Organization.

Though the number of cases reported to WHO has topped 182,000, the United Nations health watchdog cautions the real number is higher because countries are no longer required to test and report individual cases.

Health officials are gearing up for a resurgence in cases as the northern hemisphere enters winter. So far swine flu infections generally have been relatively mild, with typical flu symptoms that last about a week.

However, the pandemic virus could mutate into a more deadly form. Officials are projecting a shortfall in vaccines being rushed to market in hopes of warding off a potential global health disaster.

Faced with the unpredictable nature of flu viruses, economists say it is difficult to assess the impact of swine flu on the delicate global economic recovery taking shape amid the worst world recession since World War II.

"As the severity of A(H1N1) is so far not severe, we would not expect the magnitude of the shock to the economy to be large relative to GDP (gross domestic product)," said Simonetta Nardin, a spokeswoman at the International Monetary Fund.

"The main threat to financial stability is the risk that high levels of absenteeism could lead to breakdowns in the functioning of key financial systems," she told AFP.

School closures would exacerbate absenteeism, further reducing workplace productivity.

Nardin said that the effects of swine flu on global financial stability and the world economy would be covered in future updates of the IMF's Global Financial Stability Report and World Economic Outlook (WEO), "as warranted by events."

World Bank experts have estimated the potential economic costs of a global influenza pandemic could range from 0.7 percent to 4.8 percent of global GDP depending on the severity of the outbreak.

The lower estimate was benchmarked on the Hong Kong flu of 1968-1969, while the upper bound was based on the devastating 1918-1919 Spanish flu, which infected an estimated one third of the world's population and is estimated to have caused 50 million or more deaths.

Based on the IMF estimate of 2009 global GDP of 54.863 trillion dollars, the swine flu pandemic, using the World Bank simulation, could cost the global economy between 384 billion dollars and 2.633 trillion dollars.

"In the case of a serious flu, 70 percent of the overall economic cost would come from absenteeism and efforts to avoid infection," World Bank experts wrote in the Global Development Finance report released in June.

"Generally speaking, developing countries would be hardest hit, because higher population densities, relatively weak health care systems, and poverty accentuate the economic impacts in some countries."

The swine flu virus was first identified in California in late April and officials linked the new virus to an outbreak of illnesses in Mexico.

Mexico has borne the brunt of the economic costs of the pandemic, particularly in the transportation and tourism sectors.

"While we expect these effects to dissipate quickly following the peak of the epidemic in May, we estimate that the swine flu epidemic will have lowered GDP growth in Mexico on the order of 0.5 to 1.0 percent in 2009," an IMF official said, on condition of anonymity.

"These effects are already factored into our baseline outlook for growth in Mexico of negative 7.3 percent in 2009, as released in the July 2009 WEO," the official said.

Logged

12160 "Destroying the NWO"Check out the blogs, videos, and discussions!!http://12160.info/

Once again, a specter of flu haunts the media. Messages are conflicted. News media repeatedly mention that the H1N1 flu is generally mild, even as we are told to fear the H1N1 swine flu.

Irony abounds. Often, flu vaccines in prior flu seasons have been found to be ineffective because that season's vaccine strain was not identical to the wild-type strain that became widespread, yet recent media reports tell us that an H1N1 vaccine will be effective even if H1N1 mutates into a different strain.

The Lancet - a peer-reviewed medical journal - recently editorialized on behalf of caution in regard to fast-tracking mass vaccinations (1). After free registration, the essay can be viewed online. Oddly, The Lancet editorial mentions vaccine adjuvants but does not dwell upon their documented side-effects. Indeed, several vaccine ingredients merit concern, including mercury, aluminum, live viruses, and squalene.

For instance, despite assurances that thimerosal injections do no harm, an increasing body of peer-reviewed evidence describes adverse effects of vaccinal thimerosal (eg, 2). Aluminum is associated with neurodegeneration (eg, 3), and the adjuvant squalene is associated with arthritic pathologies and with Gulf War Syndrome (4-6).

Questions need be answered. Why is there a mass vaccination program with vaccines untested for safety when H1N1 swine flu cases are generally mild? Why a massive anti-H1N1 vaccination program when the rapidly developed H1N1 vaccine may not be effective against a mutated strain, when various H1N1 vaccine ingredients have a record of toxicity and adverse effects?

I am saddened by a possibility: Is the creating of chronic pathologies by means of vaccination an unstated intention of pharmaceutical companies and their eager servants in the FDA and CDC? Alternatively, has vaccinology become dominated by True Believers who shun findings of adverse effects?

Conclusion & recommendation: This brief essay calls attention to ironies in the so-called "H1N1 pandemic" and amid hoopla urging mass vaccination without real testing for safety. Via several online essays (4-5) and a well written, thoroughly citationed book (4b), individuals who may be subjected to untested vaccines are encouraged to read more about squalene and other adjuvants which hyper-stimulate immunity and have a track record of adverse effects.

This study investigated the association between vaccination with the Hepatitis B triple series vaccine prior to 2000 and developmental disability in children aged 1-9 years (n = 1824), proxied by parental report that their child receives early intervention or special education services (EIS). National Health and Nutrition Examination Survey 1999-2000 data were analyzed and adjusted for survey design by Taylor Linearization using SAS version 9.1 software, with SAS callable SUDAAN version 9.0.1. The odds of receiving EIS were approximately nine times as great for vaccinated boys (n = 46) as for unvaccinated boys (n = 7), after adjustment for confounders. This study found statistically significant evidence to suggest that boys in United States who were vaccinated with the triple series Hepatitis B vaccine, during the time period in which vaccines were manufactured with thimerosal, were more susceptible to developmental disability than were unvaccinated boys.

Aluminum is environmentally abundant, but not an essential element. Aluminum has been associated with several neurodegenerative diseases, such as dialysis encephalopathy, amyotrophic lateral sclerosis and Parkinsonism dementia in the Kii peninsula and Guam, and in particular, Alzheimer's disease. Although this association remains controversial, there is increasing evidence which suggests the implication of metal homeostasis in the pathogenesis of Alzheimer's disease. Aluminum, zinc, copper, and iron cause the conformational changes of Alzheimer's amyloid-beta protein. Al causes the accumulation of tau protein and amyloid-beta protein in experimental animals. Aluminum induces neuronal apoptosis in vivo as well as in vitro. Furthermore, a relationship between aluminum and the iron-homeostasis or calcium-homeostasis has been suggested. Based on these findings, the characteristics of aluminum neurotoxicity are reviewed, and the potential link between aluminum and neurodegenerative diseases is reconsidered.

Up to a third of nurses will say no to the swine flu jab because of concerns over its safety, a poll has found. NHS workers are first in line for the vaccine, but a survey of 1,500 nurses found many will reject it.

Last night a Government scientist condemned the results saying nurses who do not have the jab are putting patients at risk. Nevertheless the poll, by Nursing Times magazine, will raise questions over the Government's planned mass vaccination programme.

Of 1,500 readers, 30 per cent would not say yes to the vaccine, while 33 per cent said maybe. Just 37 per cent said they would definitely have the jab.

Of those who said they would refuse the jab, 60 per cent said their main reason was concern about the safety of the vaccine. A further 31 per cent said they did not consider the risks to their health from swine flu to be great enough, while 9 per cent thought they would not be able to take time off work to get immunised.

Some 91 per cent described themselves as frontline nurses.

One told the magazine: 'I would not be willing to put myself at risk of unknown long-term effects to facilitate a short-term solution.'

Another added: 'I have yet to be convinced there is a genuine health risk and it's not just Government propaganda.'

But Professor David Salisbury, the Department of Health's director of immunisation, reckoned it was unfortunate nurses would 'knowingly leave themselves at risk'.

He added: 'They have a duty to their patients and they have a duty to their families. I think you solve those responsibilities by being vaccinated.'

And Chief Nursing Officer Christine Beasley insisted: 'Frontline nurses will be absolutely crucial in the height of a pandemic without them, patient care will suffer and the NHS will be stretched. Getting the vaccine will protect nurses and their patients. That's why we're offering frontline nurses the vaccine as a top priority.'

The jab, currently being fast tracked, will not be fully tested before it is administered. There will be no tests at all carried out on children under three, even though babies and children at high risk will be among the first to get the vaccine.

There are also concerns the jab can cause Guillain Barre Syndrome, which can lead to paralysis and even death.

A mass swine flu vaccination in the U.S. in 1976 caused far more deaths than the disease it was designed to combat and the Health Protection Agency watchdog has asked doctors to be on the lookout for cases of GBS.

Last week Chief Medical Officer Sir Liam Donaldson announced the jab will be given to high-risk groups with asthma or diabetes, as well as health workers. Some 14 million will be covered by the first wave of the vaccination programme.

Logged

Resist. Rebel. Cry out to all peoples and nations from the sky as the lightening flashes from the east to the west and judge the living and the dead.Or choose submission and slavery.

The light shineth in darkness; and the darkness comprehended it not. (John 1:5)

All eyes are opened, or opening, to the rights of man. The general spread of the light of science has already laid open to every view the palpable truth, that the mass of mankind has not been born with saddles on their backs, nor a favored few booted and spurred, ready to ride them legitimately

In 2006 an interesting motion picture appeared via Universal Studios: “The Constant Gardener”, starring Ralph Fiennes and Rachel Weisz. The script, written based on the fictional work by author John Le Carre, has all the classic Illuminati elements: corrupt British government officials and money hungry corporate elites manipulate pharmaceutical interests in South Africa such that 62 innocent poor South Africans who live in an AIDS stricken local region die during drug trials to test a new drug for treatment of tuberculosis.

The drug does partially cure TB but often kills the patient as well. A British official’s young wife discovers the ugly truth, tries to reveal it and embarrass the British govrnment into recalling the imperfect drug and correct their flawed formula, and she dies as a result of trying to bring the truth to light. Eventually her grieving husband dies trying to vindicate her murder, but as films most often do, the scriptwriter gives us all a happy ending by writing a story that ends with the evil British officials being revealed and the truth being brought to Light.

One key element in this script really stood out for me when I watched this film again this morning. The Pharmaceutical company who landed the “global contract” to produce the TB cure stood to earn billions and billions of dollars dispensing their “cure” for a new and especially virulent strain of TB.

Let’s fast forward to 2009. We now have more than 500 FEMA concentration camps which have been built all over the USA, replete with stacks of millions of plastic coffins everywhere on the grounds of alot of these FEMA camps. This “camp building” activity has been going on for some time now, several years in fact, (see our site map and links to the FEMA REX 84 page). Citizen journalists have been reporting on it all over the USA, wondering what the FEDS and FEMA were up to. Now we know. They have developed a strain of flu by combining H5N1 and H3N2 flu viruses that will resist all existing treatment drugs except the ones they will offer through selected multinational pharmaceuticals to the infected world population, thus guaranteeing obscene profits for the makers of the treatment drugs, while reducing the world population and implementing martial law to control those populations who are left alive. What better excuse to implement martial law than an illuminati created “global flu pandemic”?

What are we being told these days about the Swine Flu? Are we being told that it could somehow “morph” into a new super flu strain that might resist all known drug treatments we have have, including Tamiflu? Are we being told that a “pandemic” is now imminent, when in fact new cases seem to be proceeding at about the same pace as any typical flu season?

HOW MUCH of what we are reading in the world media about Swine Flu is real, and how much of it is utterly fabricated “public opinion forming” global illuminati propaganda? I’d sure like to know. Below are some links for further reading and research.

JAKARTA (Reuters) – Indonesia’s first cases of the new H1N1 flu have raised concerns that if the virus spreads it could combine with the entrenched and deadly H5N1 avian influenza to create a more lethal strain of flu. Even if this worst-case scenario did not occur, experts say populous, developing countries such as Indonesia, India or Egypt, where healthcare systems can be rudimentary, will suffer more deaths from the new virus. Indonesian Health Minister Siti Fadillah Supari, who confirmed six new H1N1 cases on Sunday, said she was concerned about H1N1, widely known as swine flu, “marrying” with H5N1 avian flu. Influenza viruses not only mutate quickly and unpredictably, but they can swap genes, especially if a person or animal becomes infected with two strains at once. The new H1N1 strain is itself a mixture of various strains, genetic tests show. H5N1 bird flu has been circulating in Asia for years and has hit Indonesia harder than any other country. Although it only rarely infects people, it has killed 262 out of 433 infected globally since 2003, with 141 of those cases in Indonesia. “We are scared because we are the warehouse of the world’s most virulent H5N1,” Supari said. “I am worried if the viruses encounter each other in the field,” C.A. Nidom, the head of the Avian Influenza lab at Airlangga University in Surabaya, said. The World Health Organization declared a pandemic of H1N1 swine flu earlier this month and said the virus causes a moderately severe flu, spreading very easily from person to person. H5N1 spreads mostly from a bird to a person and stops there, but is far deadlier. The mortality rate for H1N1 is 0.2 percent, according to a study in the New England Journal of Medicine, while for H5N1 it is just over 60 percent.

SERIOUS THREAT

Scientists say usually as a virus becomes more transmissible from one human to another it also becomes less deadly, although this is not guaranteed. But Kamaruddin Zarkasie of Indonesia’s Bogor Agriculture University said he felt the risk the two viruses might combine was only a random possibility. Even if they do not, H1N1 may be a serious threat, other experts said. Ben Cowling, public health expert at the University of Hong Kong, said people with serious infections who would be admitted to hospitals in developed countries and survive might die in poorer countries. “It would be reasonable to say the mortality rate in underdeveloped settings is likely to be more comparable to the ICU (admission) rate in developed settings, or five times higher than the mortality rate in developed settings,” Cowling said. “In poorer parts of India and China … people are nutritionally less able to fight infection and they don’t have the drugs that we have in major cities,” said Robert Booy, head of clinical research at the University of Sydney’s National Center for Immunization Research & Surveillance. H1N1 has killed more than 300 people and there have been at least 67,000 confirmed cases worldwide. (Additional reporting by Karima Anjani and Tan Ee Lyn in Hong Kong; Editing by Ed Davies and Maggie Fox)

Logged

All eyes are opened, or opening, to the rights of man. The general spread of the light of science has already laid open to every view the palpable truth, that the mass of mankind has not been born with saddles on their backs, nor a favored few booted and spurred, ready to ride them legitimately

All eyes are opened, or opening, to the rights of man. The general spread of the light of science has already laid open to every view the palpable truth, that the mass of mankind has not been born with saddles on their backs, nor a favored few booted and spurred, ready to ride them legitimately

Up to half of family doctors do not want to be vaccinated against swine flu.

GPs will be first in the line for the jabs when they become available but many will decline, even though they will be offering the vaccine to their patients.

More than two thirds of those who will turn the jab down believe it has not been tested enough. Most also believe the flu has turned out to be so mild in the vast majority of cases that the vaccine is not needed.

Last night Government experts criticised GPs who decide not to have the jab, saying they will put vulnerable patients needlessly at risk.

A week ago, a poll of nurses showed that a third would turn down the opportunity of being vaccinated against swine flu.

News that medics are unconvinced by the need for a vaccine will cause grave concern to patients who will be invited for the jab over the next few months.

A poll of doctors for Pulse magazine found that 49 per cent would reject the vaccine with 9 per cent undecided.

A separate survey for GP magazine found that 29 per cent would definitely opt out of having the jab, while a further 29 per cent were unsure. Just 41 per cent said they would definitely have the jab.

Of those who said they did not want to jab, 71 per cent said it was because of safety concerns.

Richard Hoey, editor of Pulse, said: 'The medical profession has yet to be convinced by the Government's whole approach to swine flu, with most GPs now feeling that the Department of Health overreacted in its policy on blanket use of Tamiflu.

'Inevitably, that has coloured feelings about the planned immunisation campaign.

'The view among many doctors is that the Government hasn't yet made its case for why such a huge vaccination programme needs to be rushed in for what seems to be an unusually mild illness.'

But Professor David Salisbury, the Department of Health's director of immunisation, told GP magazine that frontline health workers had a duty to themselves regarding vaccination.

'They have a duty to their patients not to infect their patients and they have a duty to their families,' he said.

The Pulse survey questioned 15 doctors, while GP spoke to 216.

The poll raised further questions over the Government's planned mass vaccination programme. The jab, currently being processed, will be fast tracked and will not be fully tested before it is administered to patients.

There are also concerns the jab can spark cases of Guillain Barre Syndrome, which can lead to paralysis and even death.

A mass swine flu vaccination programme in the U.S. in 1976 caused far more deaths than the disease it was designed to combat, and the Health Protection Agency watchdog has asked doctors to look out for cases of GBS when the vaccinations begin.

Earlier this month, Chief Medical Officer Sir Liam Donaldson announced that the jab will be given to people in high-risk groups, such as those with asthma or diabetes, as well as health workers such as GPs and nurses.

Some 14million people will be covered by the first wave of the vaccination programme, with everyone else following over the next few months.

The BMA is still negotiating with doctors over how they should be paid to give out the jabs. The union is demanding £7 for every injection.

A spokesman for the BMA said: 'The new vaccine has been thoroughly tested and we believe it should provide good protection against swine flu.

'It is important that doctors are among the first to be offered the vaccine as it will not only protect them but the patients they care for.

However, doctors like all individuals have the right to decide whether they are vaccinated or not.'

anybody got death stats for other shit, I heard 500,000 (more than 5x as many) die from smoking per year

Logged

All eyes are opened, or opening, to the rights of man. The general spread of the light of science has already laid open to every view the palpable truth, that the mass of mankind has not been born with saddles on their backs, nor a favored few booted and spurred, ready to ride them legitimately

http://www.disastercenter.com/cdc/disease.htmThe 52 Infectious Diseases Designated as Notifiable at the National Level During 1997 (not shown here; but at the source link you can see the totals broken down by month, and the rate per thousand people)

Deaths from Smoking: 440,000 annual deaths each year are smoking-associated (CDC)

Death rate extrapolations for USA for Smoking: 440,000 per year, 36,666 per month, 8,461 per week, 1,205 per day, 50 per hour, 0 per minute, 0 per second. Note: this automatic extrapolation calculation uses the deaths statistic: 440,000 annual deaths each year are smoking-associated (CDC)

Logged

And the King shall answer and say unto them, Verily I say unto you, Inasmuch as ye have done it unto one of the least of these my brethren, ye have done it unto me.Matthew 25:40

WASHINGTON – A Presidential advisory group of the nation’s leading scientists and engineers today released a new report assessing the Obama Administration’s preparations for this fall’s expected resurgence of 2009-H1N1 flu and outlining key steps officials can take in the coming weeks and months to minimize the disease’s impact on the nation.

The Federal Government’s preparations for 2009-H1N1 flu have been well-organized and are scientifically grounded, according to the report by the President’s Council of Advisors on Science and Technology (PCAST), which assembled a subcommittee of experts on influenza and public health for the purpose. (PCAST is an independent group of leading scientists from academia and industry administered by the Office of Science and Technology Policy in the Executive Office of the President.) But some aspects of those preparations could and should be improved or accelerated, the group concluded.

"As the nation prepares for what could be a challenging fall, it is crucial that our public health decisions are informed by the very best scientific and technological information," said John P. Holdren, Assistant to the President for Science and Technology and a co-chair of PCAST.

The report concludes that the 2009-H1N1 flu is unlikely to resemble the deadly flu pandemic of 1918-19. But in contrast to the benign version of swine flu that emerged in 1976, the report says the current strain "poses a serious health threat" to the nation. The issue is not that the virus is more deadly than other flu strains, but rather that it is likely to infect more people than usual because it is a new strain against which few people have immunity. This could mean that doctors’ offices and hospitals may get filled to capacity.

Among the group’s prime recommendations: accelerate the preparation of flu vaccine for distribution to high-risk individuals; clarify guidelines for the use of antiviral medicines; upgrade the current system for tracking the pandemic’s progress and making resource allocation decisions; accelerate the development of communication strategies—including Web-based social networking tools—to broadcast public health messages that can help mitigate the pandemic’s impact; and identify a White House point person with primary authority to coordinate key decisions across the government as the pandemic evolves. An overarching message of the new report is that through their behavior, individuals can have a potentially big impact on the flu season’s severity. Frequent hand-washing and staying home from school or work when sick will be crucial. The report recommends intensive public education campaigns to reinforce those key behaviors, and also calls for policy adjustments that can reduce economic and other incentives that might encourage people to risk infecting others. For example, workplaces could liberalize rules for absenteeism so employees don’t feel pressured to come to work when sick and school districts could arrange alternative means of distributing lunches to children who are sick but who normally depend on school meals for adequate nourishment.

Overall, the PCAST subcommittee concluded that it was "deeply impressed" by the H1N1-related efforts underway across the Federal Government, including the breadth of issues being anticipated and addressed, the depth of thinking, the overall level of energy being devoted, and the awareness of potential pitfalls.

"The Federal Government’s response has been truly impressive and we’ve all been pleased to see the high level of cooperation among the many departments and agencies that are gearing up for the expected fall resurgence of H1N1 flu," said Harold Varmus, a PCAST co-chair and President of Memorial Sloan-Kettering Cancer Center.

"This virus has pulled us all together in common cause," said PCAST co-chair Eric Lander, who is also President and Director of the Broad Institute of Harvard and MIT. "The preparations are the best ever for an influenza pandemic."

"As the Council of Advisors on Science and Technology notes, influenza brings many challenges and agencies across the government will need to make many key decisions in the face of uncertainty about when and how the virus will play out. As we did in the spring, we can hope for the best, but we must prepare for the worst."

Administration officials leading the flu response efforts praised the report and welcomed the recommendations from the PCAST subcommittee.

"The PCAST H1N1 subcommittee report recommendations will enhance National preparedness and response to 2009-H1N1 flu, and be valuable for longer term, systematic pandemic policy coordination and planning. The President discussed this report at length with PCAST members and expressed sincere thanks for their expert contributions," said John Brennan, White House Homeland Security Advisor.

"The President has been clear from day one that he wants our H1N1 flu response to be guided by science. He also has made it clear that he believes that responding to the flu is a shared responsibility, one that requires the efforts of every American and cooperation between the private and public sectors," said Health and Human Services Secretary Kathleen Sebelius. "The Department of Health and Human Services, including the Centers for Disease Control and Prevention, National Institutes of Health, and Food and Drug Administration, has already made some important progress on the recommendations found in the PCAST subcommittee report and we plan to adopt others to ensure we are doing everything we can to keep Americans healthy and safe."

"As this PCAST report notes, it is not possible to predict how the 2009-H1N1 influenza virus or the upcoming influenza season will play out, but it is best that we plan and prepare for a resurgence of H1N1 flu," said Homeland Security Secretary Janet Napolitano. "HIN1 influenza has the potential to affect virtually every aspect of our lives, from our economy and national security to our education system. It may not be possible to stop influenza, but we can reduce the number of people who become severely ill by preparing well and acting effectively."

"Schools, child care facilities and institutions of higher learning will not only play a key role in helping to mitigate the transmission of the flu this fall but will also play a significant role in promoting critical public health information," said Secretary of Education Arne Duncan. "I am happy to report that we are well on our way to implementing many of the recommendations for schools found in this comprehensive report and have joined with our partners across government to roll out guidance for K-12 and Institutions of Higher Learning over the past two weeks."

"The President’s Council of Advisors on Science and Technology did an excellent job, working on a short timeline, of summarizing and assessing the U.S. preparations for 2009-H1N1 influenza," said CDC Director Tom Frieden. "Their subcommittee, which included individuals from across the public and private sectors, has provided valuable insights and recommendations, including strategies for strengthening our nation's ability to monitor the presence and impact of 2009-H1N1 influenza and strengthen our medical and non-medical response."

They're congratulating themselves on a job well done.What benchmark are they using to measure their success? They have no answers when asked for specifics, they use conjecture, guesswork, deception and just plain LIES.. and this is worthy of congratulations?

Logged

And the King shall answer and say unto them, Verily I say unto you, Inasmuch as ye have done it unto one of the least of these my brethren, ye have done it unto me.Matthew 25:40

Anyone know anyone who died of chicken pox lately? 98,000 people? Did they need mass graves to deal with it?

How about Chlamydia -- at 526,671 people? Seems like they might have needed 400,000 troops for that...

holy shit, who the f is looking into those stats? that is impossible, are those bodies used in the movie coma? i mean how can those stats exist without an explanation?

Logged

All eyes are opened, or opening, to the rights of man. The general spread of the light of science has already laid open to every view the palpable truth, that the mass of mankind has not been born with saddles on their backs, nor a favored few booted and spurred, ready to ride them legitimately

"To revolt is a natural tendency of life. Even a worm turns against the foot that crushes it. In general, the vitality and relative dignity of an animal can be measured by the intensity of its instinct to revolt." - Mikhail Bakunin

WASHINGTON – A Presidential advisory group of the nation’s leading scientists and engineers today released a new report assessing the Obama Administration’s preparations for this fall’s expected resurgence of 2009-H1N1 flu and outlining key steps officials can take in the coming weeks and months to minimize the disease’s impact on the nation.

The Federal Government’s preparations for 2009-H1N1 flu have been well-organized and are scientifically grounded, according to the report by the President’s Council of Advisors on Science and Technology (PCAST), which assembled a subcommittee of experts on influenza and public health for the purpose. (PCAST is an independent group of leading scientists from academia and industry administered by the Office of Science and Technology Policy in the Executive Office of the President.) But some aspects of those preparations could and should be improved or accelerated, the group concluded.

"As the nation prepares for what could be a challenging fall, it is crucial that our public health decisions are informed by the very best scientific and technological information," said John P. Holdren, Assistant to the President for Science and Technology and a co-chair of PCAST.

The report concludes that the 2009-H1N1 flu is unlikely to resemble the deadly flu pandemic of 1918-19. But in contrast to the benign version of swine flu that emerged in 1976, the report says the current strain "poses a serious health threat" to the nation. The issue is not that the virus is more deadly than other flu strains, but rather that it is likely to infect more people than usual because it is a new strain against which few people have immunity. This could mean that doctors’ offices and hospitals may get filled to capacity.

Among the group’s prime recommendations: accelerate the preparation of flu vaccine for distribution to high-risk individuals; clarify guidelines for the use of antiviral medicines; upgrade the current system for tracking the pandemic’s progress and making resource allocation decisions; accelerate the development of communication strategies—including Web-based social networking tools—to broadcast public health messages that can help mitigate the pandemic’s impact; and identify a White House point person with primary authority to coordinate key decisions across the government as the pandemic evolves. An overarching message of the new report is that through their behavior, individuals can have a potentially big impact on the flu season’s severity. Frequent hand-washing and staying home from school or work when sick will be crucial. The report recommends intensive public education campaigns to reinforce those key behaviors, and also calls for policy adjustments that can reduce economic and other incentives that might encourage people to risk infecting others. For example, workplaces could liberalize rules for absenteeism so employees don’t feel pressured to come to work when sick and school districts could arrange alternative means of distributing lunches to children who are sick but who normally depend on school meals for adequate nourishment.

Overall, the PCAST subcommittee concluded that it was "deeply impressed" by the H1N1-related efforts underway across the Federal Government, including the breadth of issues being anticipated and addressed, the depth of thinking, the overall level of energy being devoted, and the awareness of potential pitfalls.

"The Federal Government’s response has been truly impressive and we’ve all been pleased to see the high level of cooperation among the many departments and agencies that are gearing up for the expected fall resurgence of H1N1 flu," said Harold Varmus, a PCAST co-chair and President of Memorial Sloan-Kettering Cancer Center.

"This virus has pulled us all together in common cause," said PCAST co-chair Eric Lander, who is also President and Director of the Broad Institute of Harvard and MIT. "The preparations are the best ever for an influenza pandemic."

"As the Council of Advisors on Science and Technology notes, influenza brings many challenges and agencies across the government will need to make many key decisions in the face of uncertainty about when and how the virus will play out. As we did in the spring, we can hope for the best, but we must prepare for the worst."

Administration officials leading the flu response efforts praised the report and welcomed the recommendations from the PCAST subcommittee.

"The PCAST H1N1 subcommittee report recommendations will enhance National preparedness and response to 2009-H1N1 flu, and be valuable for longer term, systematic pandemic policy coordination and planning. The President discussed this report at length with PCAST members and expressed sincere thanks for their expert contributions," said John Brennan, White House Homeland Security Advisor.

"The President has been clear from day one that he wants our H1N1 flu response to be guided by science. He also has made it clear that he believes that responding to the flu is a shared responsibility, one that requires the efforts of every American and cooperation between the private and public sectors," said Health and Human Services Secretary Kathleen Sebelius. "The Department of Health and Human Services, including the Centers for Disease Control and Prevention, National Institutes of Health, and Food and Drug Administration, has already made some important progress on the recommendations found in the PCAST subcommittee report and we plan to adopt others to ensure we are doing everything we can to keep Americans healthy and safe."

"As this PCAST report notes, it is not possible to predict how the 2009-H1N1 influenza virus or the upcoming influenza season will play out, but it is best that we plan and prepare for a resurgence of H1N1 flu," said Homeland Security Secretary Janet Napolitano. "HIN1 influenza has the potential to affect virtually every aspect of our lives, from our economy and national security to our education system. It may not be possible to stop influenza, but we can reduce the number of people who become severely ill by preparing well and acting effectively."

"Schools, child care facilities and institutions of higher learning will not only play a key role in helping to mitigate the transmission of the flu this fall but will also play a significant role in promoting critical public health information," said Secretary of Education Arne Duncan. "I am happy to report that we are well on our way to implementing many of the recommendations for schools found in this comprehensive report and have joined with our partners across government to roll out guidance for K-12 and Institutions of Higher Learning over the past two weeks."

"The President’s Council of Advisors on Science and Technology did an excellent job, working on a short timeline, of summarizing and assessing the U.S. preparations for 2009-H1N1 influenza," said CDC Director Tom Frieden. "Their subcommittee, which included individuals from across the public and private sectors, has provided valuable insights and recommendations, including strategies for strengthening our nation's ability to monitor the presence and impact of 2009-H1N1 influenza and strengthen our medical and non-medical response."

To see the PCAST Recommendations and Administration Progress, click here (pdf).

By DAN CHILDSABC News Medical UnitAug. 25, 2009The government appears to be moving forward with an early roll-out of a vaccine against the H1N1 swine flu virus – even as trials to determine its safety, efficacy and proper dosage are still under way. On Tuesday, Dr. Ann Schuchat, director of the CDC's National Center for Immunization and Respiratory Diseases, confirmed that the government will request that manufacturers "fill and finish" batches of the vaccine in 15-microgram doses in order to put some doses of the vaccine into vials for shipment so they could be available as early as mid-September. The measure was one of the recommendations laid out in a report by the President's Council of Advisors on Science and Technology (PCAST) released on Monday. "We certainly feel that based on everything we know about seasonal influenza and H1N1... the risks of the disease are much higher than the risks of the vaccine," Schuchat said during a CDC press conference on the vaccine on Tuesday.

Some infectious disease experts said that given the circumstances, the plan is warranted.

"I think this is a good idea if it can be done," noted Dr. D.A. Henderson, former director of the Office of Public Health Emergency Preparedness for the Bush administration and currently an infectious disease specialist at the University of Pittsburgh Medical Center. "The only problem is that the individual may receive a less potent vaccine that will be less effective. Is it better to have this than no vaccine at all? I think so."

But others said the early roll-out could be premature. "I am very skeptical of finishing vaccine before we know the appropriate dose to be included in each inoculation, before immunogenicity studies are complete or before safety assessments have been finished," said Dr. William Schaffner, chair of the Department of Preventive Medicine at Vanderbilt University School of Medicine in Nashville, Tenn., and a proponent of influenza vaccination.

Early Push May Not Be Warranted, Flu Experts Say

"We have assured both the profession and the public that the H1N1 vaccine will be evaluated with the same rigor that is applied to seasonal vaccine," he added. "We should not make vaccine available before the trials are complete and the results carefully assessed."

Amir Afkhami, assistant professor of Psychiatry and Behavioral Sciences and of Global Health at George Washington University in Washington, D.C., agreed."I fear that a rush towards vaccinating the population without completing trials risks leading to the harmful outcome that we witnessed during the 1976 Swine flu scare where the government advocated rapid production and vaccination of the population without adequate safeguards which led to an unexplained increase in cases of Guillain Barre syndrome amongst other complications," Afkhami said. "I think in this regard we must learn from lessons of the past and be mindful of not jumping from the proverbial frying pan into the fire by putting people's health at risk without adequate production and safety monitoring of the vaccines." Too Early for 'Fill and Finish'?

Throughout the development of the new vaccine that is aimed at offering protection against the swine flu, some have raised concerns over what they see as an effort to rush the drug through safety trials.

Indeed, some of the lingering fears may spring from the spike in a rare neurological condition known as Guillain Barre syndrome cases that accompanied vaccination efforts during the 1976-77 flu season. A number of medical professionals say no strong evidence exists to support the theory that the vaccine caused the neurological disorder. However, some believe that preparing the doses before the trials are complete could open the door to unexpected side effects.

"Normally to get approval for a new vaccine you must do a variety of trials to make sure the vaccine is both safe and effective and, if there are side effects, what those may be," said Bill Muraskin, professor in the Department of Urban Studies at Queens College at the City University of New York. "Even with the biggest and best trials, there is the problem that a side effect that appears rarely may not be discovered." Push Comes Amid Sine Flu Vaccine Supply Worries

Meanwhile, with the news last month that barely more than a third of the anticipated 120 million doses of swine flu vaccine will be available by mid-October, public health experts are faced with significant pressure to ensure that vulnerable populations will have access to the shots if they are needed. One of the biggest questions that still remains is whether recipients of the vaccine will need one or two doses to get full protection from the virus. And even then, the question of whether 15 micrograms is the proper amount of antigen to have in each shot is still an unanswered one.

"Is 15ug the correct quantity?" asked Dr. Rich Whitley, president-elect of the Infectious Diseases Society of America (IDSA). "We will need the results of the NIAID studies to answer that question, as well as whether we will need to doses of novel H1N1 vaccine."

Making the Right Move Is Crucial, Experts Warn

At stake in the debate over how quickly to push forward with swine flu vaccine efforts is not only public health, but also public opinion, Muraskin warned.

"We have in this country a major anti-vaccine lobby and movement that is not confined to the lunatic fringe, but increasingly includes upper middle class groups," he said. "It is vital not to give these people ammunition.

"If the public health authorities skip any key step in the normal vaccine approval process they are setting themselves up for a real attack by the anti-vaccine forces if there are significant side effects and the flu is no more severe than what they are now predicting."

Aug. 26 (Bloomberg) -- Less than half of health-care workers in Hong Kong are willing to be vaccinated for swine flu, a survey published today in the British Medical Journal found.

The proportion of doctors, nurses and other medical professionals who plan to be immunized against H1N1, the virus that causes swine flu, was 47.9 percent when they were polled in May, researchers at the Chinese University of Hong Kong wrote. The World Health Organization declared its second-highest pandemic alert level on April 29, signifying human-to-human transmission of H1N1 in at least two countries in one region.

“The prevailing sentiment is that people don’t want to get it,” Thomas Tsang, acting controller of Hong Kong’s Centre for Health Protection, said on Aug. 23 at a meeting on influenza organized by The Lancet medical journal, China’s health ministry and the WHO. “They are afraid of all sorts of side effects.”

Health-care workers will be among the first inoculated in most countries that have announced immunization programs when manufacturers begin delivering the vaccine in the Northern Hemisphere’s autumn. The WHO’s Strategic Advisory Group of Experts on Immunization recommended last month that countries immunize medical personnel first to keep health-care systems operating and then decide which other groups should have priority.

H1N1 has infected at least 182,166 people and killed at least 1,799 around the world as of Aug. 13, the WHO reported last week. The figures are based on laboratory-confirmed cases reported to the Geneva-based UN agency, which declared a pandemic on June 11.

Seasonal Flu Shots

Most studies show that less than 60 percent of health-care workers have seasonal flu shots, according to the BMJ report.

An online survey of almost 1,500 readers of Nursing Times, a U.K. trade publication, published last week found that 30 percent didn’t plan to get vaccinated against swine flu and 37 percent did. The remainder were undecided. Liam Donaldson, England’s chief medical officer, said last week that the U.K. wouldn’t require health-care personnel to get inoculated.

The BMJ survey polled 2,255 health-care workers at 31 Hong Kong public hospital departments in self-administered, anonymous questionnaires. The study’s authors described the response rate to the poll, 48 percent, as “low.”

The researchers were surprised that more respondents -- three-quarters of whom were nurses -- didn’t plan to be vaccinated, given the impact of the 2003 SARS outbreak on Hong Kong. Those who didn’t plan to get the shot cited side effects and its effectiveness as their top reasons for declining it.

“Vaccination is one of the potentially effective measures that can reduce mortality and morbidity from pandemic influenza,” the authors wrote. “However, the effectiveness of this measure depends heavily on the uptake rate in those groups assigned high priority.”

Logged

All eyes are opened, or opening, to the rights of man. The general spread of the light of science has already laid open to every view the palpable truth, that the mass of mankind has not been born with saddles on their backs, nor a favored few booted and spurred, ready to ride them legitimately

Emeritus Professor, Department of Microbiology and Immunology, New York Medical College, New York, New York, USA. [email protected]

Although no viruses are better understood or more intensively studied than the viruses of influenza, if the next influenza pandemic occurs within the next 5-10 years its control will depend on innovations in vaccine production developed more than 40 years ago, but not yet applied to the full extent demanded by our present hard-won knowledge of the epidemiology of the disease. We have become so enamored of the brilliant advances made in the interim in understanding the molecular biology of both virus and host that common sense and inexpensive implementation of proven and older methods of control have been neglected as an interim barricade. In this review, I have advocated a return to first principles, while embracing the promise and returns of contemporary research. With the assumption that the next pandemic virus will contain one of the 13 influenza A virus hemagglutinin subtypes not currently causing epidemic human disease, high-yield reassortant viruses of each of these subtypes should be produced with all dispatch and, in collaboration with industry, tested for production stability and immunogenicity in humans. From this archive, an appropriate reassortant could be selected within days or weeks, and production could ensue. If not a perfect match with the imminent pandemic virus, this "barricade vaccine" could stand as a first line of defense until supplanted by a definitive "rampart vaccine," matching better the emergent, potentially pandemic virus.

Logged

"Civilization" has gone completely forking mad and I am taking my family and running for the hills.

"Over the course of the next few months, with the assistance of our partners in the private and public sector and at every level of government, we will move aggressively to prepare the nation for the possibility of a more severe outbreak of the H1N1 virus. We will do all we can to plan for different scenarios. We ask the American people to become actively engaged with their own preparation and prevention. It’s a responsibility we all share." (US Government advisory, flu.gov: Vaccines, Vaccine Allocation and Vaccine Research )

A Worldwide public health emergency is unfolding on an unprecedented scale. 4.9 billion doses of H1N1 swine flu vaccine are envisaged by the World Health Organization (WHO).

A report by President Obama's Council of Advisors on Science and Technology "considers the H1N1 pandemic 'a serious health threat; to the U.S. — not as serious as the 1918 Spanish flu pandemic but worse than the swine flu outbreak of 1976.":

"It's not that the new H1N1 pandemic strain is more deadly than previous flu threats, but that it is likely to infect more people than usual because so few people have immunity" (Get swine flu vaccine ready: U.S. advisers)

Responding to the guidelines set by the WHO, preparations for the inoculation of millions of people are ongoing, in the Americas, the European Union, in South East Asia and around the World. Priority has been given to health workers, pregnant women and children. In some countries, the H1N1 vaccination will be compulsory.

In the US, the state governments are responsible for these preparations, in coordination with federal agencies. In the State of Massachusetts, legislation has been introduced which envisages hefty fines and prison sentences for those who refuse to be vaccinated. (See VIDEO; Compulsory Vaccination in America?)

The US military is slated to assume an active role in the public health emergency

Schools and colleges across North America are preparing for mass vaccinations. (See CDC H1N1 Flu | Resources for Schools, Childcare Providers, and Colleges)

In Britain, the Home Office has envisaged the construction of mass graves in response to a rising death toll. The British Home Office report calls for "increasing mortuary capacity" An atmosphere of panic and insecurity prevails. (See Michel Chossudovsky Fear, Intimidation & Media Disinformation: U.K Government is Planning Mass Graves in Case of H1N1 Swine Flu Pandemic)

The government appears to be moving forward with an early roll-out of a vaccine against the H1N1 swine flu virus – even as trials to determine its safety, efficacy and proper dosage are still under way.

On Tuesday, Dr. Ann Schuchat, director of the CDC's National Center for Immunization and Respiratory Diseases, confirmed that the government will request that manufacturers "fill and finish" batches of the vaccine in 15-microgram doses in order to put some doses of the vaccine into vials for shipment so they could be available as early as mid-September. The measure was one of the recommendations laid out in a report by the President's Council of Advisors on Science and Technology (PCAST) released on Monday.

sociostudent

Everyone look up "reversion to virulence" and "Recombination resulting in virulence shift" and remember what those mean, because that's what's going to end up happening if they keep using the flumist on some people and changing their mind about the vaccine strains.

WASHINGTON — A judge on Wednesday denied an advocacy group's bid to prevent the government from giving pregnant women flu vaccines with a preservative that contains mercury.

Leaders of the Coalition for Mercury-Free Drugs say their effort took on a new urgency when a government advisory committee recently recommended that pregnant women be among the first people to get swine flu vaccinations when the vaccine becomes available this fall.

A small amount of the mercury-containing preservative thimerosal is in most influenza shots, including swine flu vaccines, but some are produced thimerosal-free. The coalition argued that pregnant women should only get the thimerosal-free version because of a risk that the mercury in the shot could poison a fetus and cause medical problems, including autism.

But U.S. District Judge Reggie Walton ruled against the group's request for a preliminary injunction because he said the group couldn't prove that pregnant women they represent would get vaccines containing thimerosal.

Walton said he would consider further written arguments in the next month about whether the lawsuit can continue.

Thimerosal used to be used in a number of vaccines, but manufacturers began removing the preservative from all routine child vaccines in 2001 as a precaution. But numerous large studies have shown no link between thimerosal and autism, or other health problems.On the Net:Coalition for Mercury-Free Drugs: http://mercury-freedrugs.org/Background from Centers for Disease Control and Prevention: http://tinyurl.com/konff8

Logged

All eyes are opened, or opening, to the rights of man. The general spread of the light of science has already laid open to every view the palpable truth, that the mass of mankind has not been born with saddles on their backs, nor a favored few booted and spurred, ready to ride them legitimately